Coronary disease & ACS

Heart Failure During Acute Coronary Syndrome and the Long-Term Cancer Risk: The ABC-9 Study on Heart Disease

ESC Heart FailPublished Prospective cohort study

Authors' conclusion

An inverse association between baseline HF and long-term cancer risk has been observed among the ABC Study on heart disease patients who were followed for 24 years after ACS.

Study context

Population
Patients admitted with acute coronary syndrome (ACS), discharged cancer-free, followed 24 years
Participants
572 patients6,440 person-years
Exposure
Heart failure (HF) vs no HF during ACS hospitalisation
  • HFn = 192
Outcome
Long-term cancer risk (cancer onset and cancer death)
Follow-up
24 years
Methodological details3 Italian hospitals, propensity-score matched analysis
  • 3 Italian hospitals
  • Propensity-score matched analysis

Main finding

As reported in the abstract

Cancer onset

No HF

103

events

HF

26

events

Competing risk regression
Subdistribution hazard ratio (95% CI)P value
HFvs No HF
0.47(0.30–0.72)
P = 0.001
LVEF
1.02(1.01–1.04)
P = 0.002

Observational data: associations, not effects.

Further findings

OutcomeNo HFSHR (95% CI)P value
Cancer deathHFvs No HFFully adjusted model81 events0.63 (0.37–1.05)P = 0.08

Cancer death

SHR (95% CI)P value
LVEFFully adjusted model1.02 (0.99–1.06)P = 0.08
  • Cancer death: total cancer deaths 107 (19%)

Cancer risk by HF phenotype (HFpEF, HF with mildly reduced EF, HFrEF)

No difference in cancer risk

Propensity-score matched analysis

Consistent results (192 pairs)

Interactions with age

Negative interaction between age and HF and positive interaction between age and left ventricular ejection fraction (LVEF) for cancer risk

Original publication

Heart Failure During Acute Coronary Syndrome and the Long-Term Cancer Risk: The ABC-9 Study on Heart Disease. ESC Heart Fail. Published 20 February 2024. doi:10.1002/ehf2.14668

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.